Tenet Healthcare is a medical care facility company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker THC on the NYSE exchange.
Tenet Healthcare stock last closed at $173.63, up 1.36% from the previous day, and has increased 32.03% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.41 percentage points. Tenet Healthcare stock is currently +58.1% from its 52-week low of $109.82, and -2.08% from its 52-week high of $177.32.
As of Jun 27, 2025, there are 92.89M THC shares outstanding. The market capitalization of THC is $16.13B. In the past 24 hours, 1.55M THC shares were traded.
You will need an online brokerage account to access the NYSE market and buy THC stock.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal details so you can invest in THC stock today.
Now that you have filled out your info on the stocks app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new investment account.
After you have figured out the best place to buy Tenet Healthcare stock, it's critical to evaluate their stock before you invest, so you truly understand the risk as well as the opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on THC's stock page.
You can use many financial metrics, analyses, models, and charts to gauge THC's true value.
Using relative valuations measures:
You can access additional valuation analysis on THC's stock here.
Out of 12 Equities analysts who research THC, the consensus analyst rating on Tenet Healthcare is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Jamie Perse, a top 17% analyst from Goldman Sachs maintains THC with a hold rating and raises their THC price target from $134.00 to $154.00, on May 5, 2025.
Ben Hendrix, a top 21% analyst from RBC Capital maintains THC with a buy rating and raises their THC price target from $183.00 to $189.00, on Apr 30, 2025.
A.J. Rice, a top 11% analyst from UBS maintains THC with a strong buy rating and raises their THC price target from $217.00 to $230.00, on Apr 30, 2025.
UBS's A.J. Rice raised their price target on Tenet Healthcare (NYSE: THC) by 6% from $217 to $230 on 2025/04/30. The analyst maintained their Strong Buy rating on the stock.
Tenet Healthcare reported its Q1 2025 earnings.
Rice attributed their price target hike to the print revealing "labor efficiencies driving a fundamental outperformance, and a runway that remains outsized for the company's high-acuity ambulatory surgery center strategy.
For Q1 2025, Tenet Healthcare reported:
For FY 2025, management guided:
Chairman & CEO Saum Sutaria, M.D., commented: "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations.
"We continue to expand access to high-quality specialty care as we effectively execute on our mission to deliver quality, compassionate care in the communities we serve."
Michael Ha, a bottom 7% analyst from Baird downgrades THC to a hold rating and lowers their THC price target from $153.00 to $137.00, on Apr 15, 2025.
Jason Cassorla, a bottom 10% analyst from Guggenheim initiates coverage on THC with a strong buy rating and announces their THC price target of $165.00, on Apr 9, 2025.
You can dig deeper into what analysts are saying on the Tenet Healthcare stock forecast page.
Last year, THC earnings were $1.46B. In the last four year, THC's earnings have gone up by 41.51% per year. This was faster than the Medical Care Facilities industry average of 18.25%.
Last year, THC revenue was $20.53B. During the past 5 year, THC's revenue has increased by 2.16% per year. This was slower than the Medical Care Facilities industry average of 7.13%.
Dig into THC's earnings and revenue performance here.
In the past year, insiders at THC have sold more shares than they have bought.
Paola M. Arbour, EVP Chief Information Officer of THC, was the latest THC insider to sell. They sold $1,338,674.00 worth of THC shares on Jun 5, 2025.
Dig into more about who owns THC shares here.
No, Tenet Healthcare doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary options:
Hit the Open Trade button and eToro will place the order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some THC shares, you'll want to keep up with your investment.
Add THC to a watchlist to get notified of the latest news about your THC stock.
To summarize, here are the 6 steps to buy Tenet Healthcare stock:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Tenet Healthcare, create a watchlist on WallStreetZen today.